Nothing Special   »   [go: up one dir, main page]
Next Article in Journal / Special Issue
Biological and Pharmacological Properties of Carbon Monoxide: A General Overview
Previous Article in Journal
Validation and Bias Correction of Monthly δ18O Precipitation Time Series from ECHAM5-Wiso Model in Central Europe
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Oxygen
Volume 2
Issue 2
10.3390/oxygen2020011
oxygen-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Oxygenation of Newborns

by
Ola Didrik Saugstad
1,2,* and
Jannicke Hanne Andresen
3
1
Department of Pediatric Research, University of Oslo, 0424 Oslo, Norway
2
Ann and Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
3
Department of Neonatology, Oslo University Hospital, 0424 Oslo, Norway
*
Author to whom correspondence should be addressed.
Oxygen 2022, 2(2), 125-129; https://doi.org/10.3390/oxygen2020011
Submission received: 4 May 2022 / Revised: 15 May 2022 / Accepted: 19 May 2022 / Published: 23 May 2022
(This article belongs to the Special Issue Review Papers in Oxygen)
Review Reports Versions Notes

Abstract

:
The last 20–30 years, the oxygen exposure of newborn infants has been substantially reduced. This is mainly due to a dramatic reduction in the use of oxygen in the delivery room in newborn infants in need of positive pressure ventilation (PPV) and the better control of oxygen saturation with clearly defined targets in immature infants in need of supplemental oxygen during treatment in neonatal intensive care units. Term and near-term infants in need of IPPV in the delivery room should start with a FiO2 of 0.21. Between 28 and 31 weeks of gestation, an initial FiO2 of 0.21–0.30 is generally recommended. For immature infants, a higher FiO2 than 0.3 may be needed, although the optimal initial level is not defined. For all groups, it is recommended to adjust the FiO2 according to oxygen saturation (SpO2) and heart rate response. For immature infants, the combination of prolonged bradycardia and an SpO2 not reaching 80% within 5 min of life is associated with a substantially increased risk of death. For immature infants beyond the delivery room, an SpO2 target between 91 and 95% is recommended.

1. Introduction

Oxygen is one of the most critical components of life. Nature has taken billions of years to develop optimal atmospheric oxygen concentrations for human life, evolving from anaerobic conditions before reaching today’s level of 20.95%. Life therefore evolved within an oxygen-poor atmosphere, and oxygen was primarily produced by photosynthesis as a waste product by prokaryotic, and later, eukaryotic organisms 3.5 billion years ago and by oceanic cyanobacteria a billion years after this. Photosynthesis by cyanobacteria soon led to the accumulation of atmospheric oxygen, which oxidized methane, a strong greenhouse gas, to carbon dioxide and water, which then reduced the greenhouse effect with subsequent planetary cooling. Approximately 2.3 billion years ago, a rapid increase in low atmospheric oxygen occurred, resulting in oxygen levels that at some stage were probably as high as 30%. During this period, life was able to develop antioxidant defenses as protection against hyperoxia and oxidative stress [1,2]. In fetal life, oxygen tension is low, and it seems that redox processes are of importance in regulating embryogenesis and fetal development [3].
Oxygen was described by Scheele as an element in approximately 1772. Although Priestly in his original article on oxygen in 1774 warned against the possible toxic effects of pure oxygen, it quickly became a ubiquitous medical treatment, including in newborn care [4]. Oxygen was applied in newborn resuscitation for about 200 years before the first critical appraisal of its safety occurred. With the introduction of the Apgar score in 1953 [5], oxygen was used routinely in many centers to “pink up” newborns in order to achieve a higher Apgar score. As late as in 1992, the American Heart Association guidelines for newborn resuscitation stated: “there is no reason to be concerned giving pure oxygen a brief period after birth” [6]. Moreover, within the field, there was a prevailing dogma that if oxygen was not available at the initiation of resuscitation, attempts with air would be futile and were often withheld. Pure oxygen continued to be recommended in all newborn resuscitation guidelines until 1998, when the WHO first suggested air [7], and in 2010, ILCOR did the same [8]. However, previously, in the late 1970s, we questioned the necessity and safety of this practice [9]. There is now increased understanding of the potential toxicity of both too much and too little oxygen, especially for preterm and asphyxiated newborn infants, and of the potential lifelong impact of oxygen exposure, even for a few minutes after birth [10].

2. Methods and Materials

This is not a full systematic review. However, data were extracted from publications listed in Pubmed in the field of oxygenation of newborns in the delivery room, and oxygenation of immature infants beyond the delivery room. Systematic reviews and meta-analyses regarding these topics were identified.

3. Results

3.1. Oxygenation in the Delivery Room

Air for newborn resuscitation was tested in randomized and pseudo-randomized studies from the early 1990s. Meta-analyses in this field clearly show that when compared to 100% O2, air reduces mortality by approximately 30% in term and near-term newborn infants [11,12]. A recent study in newborn hypoxic piglets applying Near Infrared Spectroscopy (NIRS) showed that reoxygenation improves splanchnic oxygenation; however, when applying 100% O2, the intestine was exposed to hyperoxia [13].
For newborn infants < 32 weeks of gestational age, the data are less clear. It seems 21% or 30% oxygen may safely be applied for infants between 28 and 32 weeks. For immature infants (≤28 weeks of gestational age), a higher initial FiO2 seems to be needed [14,15,16]. The optimal level is, however, not known [17]. A recent study showed that appropriate adjustments of FiO2 are far more important than which initial FiO2 is chosen [18]. For this reason, many investigators in this field would recommend starting out with 30% O2 for infants < 29 weeks GA and titrate FiO2 according to the development of oxygen saturation measured using pulse oximetry (SpO2). The target for titration should be SpO2 80–85% within 5 min of life [19] and the avoidance of bradycardia. A combination of hypoxemia (SpO2 < 80%) and bradycardia (heart rate < 100 bpm) ≥ 2 min during the first 5 min of life is associated with an increased risk of death, 18-fold compared to normoxemia and heart rate < 100 bpm [20].

3.2. Oxygenation beyond the Delivery Room

Immature infants < 28 weeks GA have been particularly studied. The so-called Neoprom study consisting of five individual studies from the USA, the Canada, UK, New Zealand, and Australia tested the effect of lower (85–89%) versus higher (91–95%) SpO2 target from birth to corrected term age in 4911 infants. The lower target group had higher mortality (19.3% vs. 16.2%), relative risk (RR) 1.41, and 95% confidence intervals (CI) 1.14–1.74, higher severe necrotizing enterocolitis (RR 1.25, 95% CI 1.05–1.49), but lower retinopathy of prematurity with RR 0.74 (95% CI 0.59–0.92) than the higher target group [21,22,23]. Most guidelines therefore recommend an SpO2 target of 91–95% with very close alarm limits [24].

3.3. Present Practice

A recent survey by Sotiropoulos et al. [25] demonstrated that in moderate to late preterm infants, most units initiated respiratory support in the delivery room with an FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2. Most (89%) considered heart rate as a more important indicator of response than SpO2. Almost all (96%) supported the need for well-designed trials to examine oxygenation in moderate–late preterm delivery room resuscitation. The survey demonstrated that most clinicians seem to resuscitate moderate–late preterm infants with a lower initial FiO2, but there is a hesitance to target SpO2 or titrate FiO2. Most consider heart rate as a more important indicator of infant response than SpO2 [25]. In low-income countries, the lack of oxygen blenders makes it more difficult to follow such guidelines [26]. Further, a recent survey regarding guidelines showed that the SpO2 target at 5 min varied considerably, between 70 and 90% [27].

3.4. New Technology

Delayed cord clamping leads to a higher and more rapid increase in SpO2 in the first few minutes after birth [28,29,30]. The published target ranges for SpO2 the first 10 min of life are based on early cord clamping [31]. New curves therefore need to be developed based on delayed cord clamping. Most extremely premature infants have respiratory instability that can manifest as frequent episodes of intermittent hypoxemia. Although caregivers target clinically recommended ranges of SpO2, the consistent maintenance of these ranges is not always achieved. The excessive administration of supplemental oxygen combined with limited staff resources increases exposure to SpO2 levels outside of the desired range. In this population, exposure to hyperoxemia and prolonged episodes of intermittent hypoxemia have been associated with damage to the eye and lung and impaired neurodevelopment. To improve SpO2 targeting, various systems for the automated control of inspired oxygen have been developed and are commercially available at an increasing rate. There are no follow up data on the impact of these automated FiO2 adjustment systems on mortality or morbidity [32,33,34]. However, the method has potential to improve outcomes for preterm neonates with their inherent respiratory instability.

4. Conclusions

Term and near-term infants in need of positive pressure ventilation at birth have an approximately 30% reduction in mortality rate when this procedure is initiated with air instead of pure oxygen. For preterm infants < 32 weeks of gestational age, there seems to be an agreement amongst clinicians that there is a need for more large and robust clinical trials examining oxygen use in general for immature infants but also for moderate–late preterm resuscitation. Further, there is a need to focus on the titration of FiO2 as much as the initial FiO2 chosen and examine the long-term neurodevelopmental outcomes in particular [17,18].
For oxygenation beyond the delivery room, we do not have solid data except for immature infants with gestational age < 28 weeks GA. A high-SpO2 approach (target between 91 and 95%) is preferred.
In the last 10–15 years, the oxygen exposure—and probably also oxidative stress—of newborn infants has been dramatically reduced. This may be reflected in improved health in adulthood. Long-term follow-up is highly needed to shed light on the issues related to the oxygenation of newborns. The studies summarized in this review have contributed to dramatic changes in the clinical handling of newborn babies, resulting in significantly lower mortality and morbidity rates.

Author Contributions

Conceptualization, O.D.S. and J.H.A.; methodology O.D.S.; software, O.D.S. and J.H.A.; validation, O.D.S. and J.H.A.; formal; writing—original draft preparation, O.D.S. and J.H.A.; writing—review and editing, O.D.S. and J.H.A.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Saugstad, O.D.; Oei, J.L.; Lakshminrusimha, S.; Vento, M. Oxygen therapy of the newborn from molecular understanding to clinical practice. Pediatr. Res. 2019, 85, 20–29. [Google Scholar] [CrossRef] [PubMed]
  2. Andresen, J.H.; Saugstad, O.D. Oxygen metabolism and oxygenation of the newborn. Semin. Fetal Neonatal Med. 2020, 25, 101078. [Google Scholar] [CrossRef] [PubMed]
  3. Mancardi, D.; Ottolenghi, S.; Attanasio, U.; Tocchetti, C.G.; Paroni, R.; Pagliaro, P.; Samaja, M. Janus, or the inevitable battle between too much and too little oxygen. Antioxid. Redox Signal. 2022. ahead of print. [Google Scholar] [CrossRef] [PubMed]
  4. Mathias, M.; Chang, J.; Perez, M.; Saugstad, O. Supplemental Oxygen in the Newborn: Historical Perspective and Current Trends. Antioxidants 2021, 25, 1879. [Google Scholar] [CrossRef]
  5. Apgar, V. A proposal for a new method of evaluation of the newborn infant. Curr. Res. Anesth. Analg. 1953, 32, 260–267. [Google Scholar] [CrossRef]
  6. Kerber, R.E.; Ornato, J.P.; Brown, D.D.; Chameides, L.; Chandra, N.C.; Cummins, R.O.; Hazinski, M.F.; Melker, R.J.; Weaver, W.D.; Abramson, N.S.; et al. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Part VII. Neonatal resuscitation. JAMA 1992, 268, 2276–2281. [Google Scholar]
  7. World Health Organization. Basic Newborn Resuscitation: A Practical Guide; World Health Organization: Geneva, Switzerland, 1998. [Google Scholar]
  8. Wyllie, J.; Perlman, J.M.; Kattwinkel, J.; Atkins, D.L.; Chameides, L.; Goldsmith, J.P.; Guinsburg, R.; Hazinski, A.F.; Morley, C.; Richmond, S.; et al. Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2010, 81 (Suppl. S1), e260–e287. [Google Scholar] [CrossRef]
  9. Saugstad, O.D.; Aasen, A.O. Plasma hypoxanthine concentrations in pigs. A prognostic aid in hypoxia. Eur. Surg. Res. 1980, 12, 123–129. [Google Scholar] [CrossRef]
  10. Perez, M.; Robbins, M.E.; Revhaug, C.; Saugstad, O.D. Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period. Free Radic. Biol. Med. 2019, 142, 61–72. [Google Scholar] [CrossRef]
  11. Saugstad, O.D.; Ramji, S.; Soll, R.F.; Vento, M. Resuscitation of newborn infants with 21% or 100% oxygen: An updated systematic review and meta-analysis. Neonatology 2008, 94, 176–182. [Google Scholar] [CrossRef]
  12. Welsford, M.; Nishiyama, C.; Shortt, C.; Isayama, T.; Dawson, J.A.; Weiner, G.; Roehr, C.C.; Wyckoff, M.H.; Rabi, Y. Room Air for Initiating Term Newborn Resuscitation: A Systematic Review With Meta-analysis. Pediatrics 2019, 143, e20181825. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Dotinga, B.M.; Solberg, R.; Saugstad, O.D.; Bos, A.F.; Kooi, E.M.W. Splanchnic oxygen saturation during reoxygenation with 21% or 100% O2 in newborn piglets. Pediatr. Res. 2021. [Google Scholar] [CrossRef] [PubMed]
  14. Oei, J.L.; Saugstad, O.D.; Lui, K.; Wright, I.M.; Smyth, J.P.; Craven, P.; Wang, Y.A.; McMullan, R.; Coates, E.; Ward, M.; et al. Targeted Oxygen in the Resuscitation of Preterm Infants, a Randomized Clinical Trial. Pediatrics 2017, 139, e20161452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Oei, J.L.; Vento, M.; Rabi, Y.; Wright, I.; Finer, N.; Rich, W.; Kapadia, V.; Aune, D.; Rook, D.; Tarnow-Mordi, W.; et al. Higher or lower oxygen for delivery room resuscitation of preterm infants below 28 completed weeks gestation: A meta-analysis. Arch. Dis. Child.-Fetal Neonatal Ed. 2017, 102, F24–F30. [Google Scholar] [CrossRef]
  16. Oei, J.L.; Kapadia, V.; Rabi, Y.; Saugstad, O.D.; Rook, D.; Vermeulen, M.J.; Boronat, N.; Thamrin, V.; Tarnow-Mordi, W.; Smyth, J.; et al. Neurodevelopmental outcomes of preterm infants after randomisation to initial resuscitation with lower (FiO2 < 0.3) or higher (FiO2 > 0.6) initial oxygen levels. An individual patient meta-analysis. Arch. Dis. Child.-Fetal Neonatal Ed. 2021. [Google Scholar] [CrossRef]
  17. Vento, M.; Saugstad, O.D. Targeting Oxygen in Term and Preterm Infants Starting at Birth. Clin. Perinatol. 2019, 46, 459–473. [Google Scholar] [CrossRef]
  18. Saugstad, O.D.; Kapadia, V.; Oei, J.L. Oxygen in the First Minutes of Life in Very Preterm Infants. Neonatology 2021, 118, 218–224. [Google Scholar] [CrossRef]
  19. Gottimukkala, S.B.; Sotiropoulos, J.X.; Lorente-Pozo, S.; Monti Sharma, A.; Vento, M.; Saugstad, O.D.; Oei, J.L. Oxygen saturation (SpO2) targeting for newborn infants at delivery: Are we reaching for an impossible unknown? Semin. Fetal Neonatal Med. 2021, 26, 101220. [Google Scholar] [CrossRef]
  20. Kapadia, V.; Oei, J.L.; Finer, N.; Rich, W.; Rabi, Y.; Wright, I.M.; Rook, D.; Vermeulen, M.J.; Tarnow-Mordi, W.O.; Smyth, J.P.; et al. Outcomes of delivery room resuscitation of bradycardic preterm infants: A retrospective cohort study of randomised trials of high vs. low initial oxygen concentration and an individual patient data analysis. Resuscitation 2021, 167, 209–217. [Google Scholar] [CrossRef]
  21. Saugstad, O.D.; Aune, D. Optimal oxygenation of extremely low birth weight infants: A meta-analysis and systematic review of the oxygen saturation target studies. Neonatology 2014, 105, 55–63. [Google Scholar] [CrossRef]
  22. Manja, V.; Lakshminrusimha, S.; Cook, D.J. Oxygen saturation target range for extremely preterm infants: A systematic review and meta-analysis. JAMA Pediatr. 2015, 169, 332–340. [Google Scholar] [CrossRef] [PubMed]
  23. Askie, L.M. Meta-analysis of Oxygenation Saturation Targeting Trials: Do Infant Subgroups Matter? Clin. Perinatol. 2019, 46, 579–591. [Google Scholar] [CrossRef] [PubMed]
  24. Sweet, D.G.; Carnielli, V.; Greisen, G.; Hallman, M.; Ozek, E.; Te Pas, A.; Plavka, R.; Roehr, C.C.; Saugstad, O.D.; Simeoni, U.; et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome—2019 Update. Neonatology 2019, 115, 432–450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Sotiropoulos, J.X.; Kapadia, V.; Vento, M.; Rabi, Y.; Saugstad, O.D.; Kumar, R.K.; Schmölzer, G.M.; Zhang, H.; Yuan, Y.; Lim, G.; et al. Oxygen for the delivery room respiratory support of moderate-to-late preterm infants. An international survey of clinical practice from 21 countries. Acta Paediatr. 2021, 110, 3261–3268. [Google Scholar] [CrossRef]
  26. Koh, J.; Yeo, C.L.; Wright, I.; Lui, K.; Saugstad, O.; Tarnow-Mordi, W.; Smyth, J.; Oei, J.L. The use of oxygen for delivery room resuscitation of newborn infants in non-Western countries. Early Hum. Dev. 2012, 88, 631–635. [Google Scholar] [CrossRef]
  27. Wilson, A.; Vento, M.; Shah, P.S.; Saugstad, O.; Finer, N.; Rich, W.; Morton, R.L.; Rabi, Y.; Tarnow-Mordi, W.; Suzuki, K.; et al. A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatr. 2018, 107, 20–27. [Google Scholar] [CrossRef] [Green Version]
  28. Ashish, K.C.; Singhal, N.; Gautam, J.; Rana, N.; Andersson, O. Effect of early versus delayed cord clamping in neonate on heart rate, breathing and oxygen saturation during first 10 minutes of birth—Randomized clinical trial. Matern. Health Neonatol. Perinatol. 2019, 5, 7. [Google Scholar]
  29. Padilla-Sánchez, C.; Baixauli-Alacreu, S.; Cañada-Martínez, A.J.; Solaz-García, Á.; Alemany-Anchel, M.J.; Vento, M. Delayed vs. Im mediate Cord Clamping Changes Oxygen Saturation and Heart Rate Patterns in the First Minutes after Birth. J. Pediatr. 2020, 227, 149–156.e1. [Google Scholar] [CrossRef]
  30. Lara-Cantón, I.; Badurdeen, S.; Dekker, J.; Davis, P.; Roberts, C.; Te Pas, A.; Vento, M. Oxygen saturation and heart rate in healthy term and late preterm infants with delayed cord clamping. Pediatr. Res. 2022. [Google Scholar] [CrossRef]
  31. Dawson, J.A.; Kamlin, C.O.; Vento, M.; Wong, C.; Cole, T.J.; Donath, S.M.; Davis, P.G.; Morley, C.J. Defining the reference range for oxygen saturation for infants after birth. Pediatrics 2010, 125, e1340–e1347. [Google Scholar] [CrossRef] [Green Version]
  32. Claure, N.; Bancalari, E. New Modes of Respiratory Support for the Premature Infant: Automated Control of Inspired Oxygen Concentration. Clin. Perinatol. 2021, 48, 843–853. [Google Scholar] [CrossRef] [PubMed]
  33. Mitra, S.; Singh, B.; El-Naggar, W.; McMillan, D.D. Automated versus manual control of inspired oxygen to target oxygen saturation in preterm infants: A systematic review and meta-analysis. J. Perinatol. 2018, 38, 351–360. [Google Scholar] [CrossRef] [PubMed]
  34. Mitra, S.; McMillan, D. Automated control of fraction of inspired oxygen: Is it time for widespread adoption? Curr. Opin. Pediatr. 2021, 33, 209–216. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saugstad, O.D.; Andresen, J.H. Oxygenation of Newborns. Oxygen 2022, 2, 125-129. https://doi.org/10.3390/oxygen2020011

AMA Style

Saugstad OD, Andresen JH. Oxygenation of Newborns. Oxygen. 2022; 2(2):125-129. https://doi.org/10.3390/oxygen2020011

Chicago/Turabian Style

Saugstad, Ola Didrik, and Jannicke Hanne Andresen. 2022. "Oxygenation of Newborns" Oxygen 2, no. 2: 125-129. https://doi.org/10.3390/oxygen2020011

APA Style

Saugstad, O. D., & Andresen, J. H. (2022). Oxygenation of Newborns. Oxygen, 2(2), 125-129. https://doi.org/10.3390/oxygen2020011

Article Metrics

Back to TopTop